Replies to post #279304 on Avid Bioservices Inc (CDMO)

[goodJohnhunting]

and pd1 only worked w/ 30% yet $40 bil market cap attributable to such losers...

the best hitters in baseball fail 70% of time yet get paid millions..

if they can demonstrate where bavi can be effective then value should follow..

also, b2gp1 is still a mystery...

PDL1 expression values in relation to specific cancers are well known. And also, these values don't change related to how much therapeutic is administered.

However, that doesn't mean that B2GP1 would not be of value in some capacity going forward. The key point is moving forward.

All the best,
John